Hester Biosciences Limited (BOM:524669)
1,416.90
-42.85 (-2.94%)
At close: Jan 20, 2026
Hester Biosciences Revenue
Hester Biosciences had revenue of 806.96M INR in the quarter ending September 30, 2025, a decrease of -5.65%. This brings the company's revenue in the last twelve months to 3.11B, down -1.85% year-over-year. In the fiscal year ending March 31, 2025, Hester Biosciences had annual revenue of 3.12B with 0.41% growth.
Revenue (ttm)
3.11B
Revenue Growth
-1.85%
P/S Ratio
3.78
Revenue / Employee
5.53M
Employees
562
Market Cap
11.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.12B | 12.80M | 0.41% |
| Mar 31, 2024 | 3.11B | 329.89M | 11.86% |
| Mar 31, 2023 | 2.78B | 315.58M | 12.79% |
| Mar 31, 2022 | 2.47B | 289.51M | 13.30% |
| Mar 31, 2021 | 2.18B | 299.33M | 15.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dynacons Systems & Solutions | 13.21B |
| Rupa & Company | 12.40B |
| Apollo Pipes | 11.33B |
| Centrum Capital | 7.78B |
| Atul Auto | 7.56B |
| Ultramarine & Pigments | 7.54B |
| Bajaj HealthCare | 6.11B |
| Syncom Formulations (India) | 5.15B |
Hester Biosciences News
- 6 months ago - Q1 2026 Hester Biosciences Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Hester Biosciences shares rally 15% as Q1 profit soars 131% YoY to Rs 17.3 crore, revenue rises 2% - Business Upturn
- 1 year ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 1 year ago - Hester Biosciences shares surge over 11% following strong Q2 FY25 performance - Business Upturn
- 1 year ago - Hester Biosciences Q2: Revenue jumps 18.8% YoY to ₹83.69 crores, PAT surges 107.4% YoY to ₹8.39 crores - Business Upturn